Skip to main content

Table 1 Therapeutic modalities to treat cardiac allograft vasculopathy

From: What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?

Antiproliferative agents:
Angiopeptin
Low-molecular weight heparin
Antimetabolites:
Methotrexate
Antithrombotic agents:
Hirulog
Antithrombin III
Monoclonal antibodies:
Growth factors
Adhesion molecules
Cytokines
Antihypertensive agents:
Calcium channel blockers
ACE inhibitors
New immunosuppressive agents
Use of photopheresis
Lipid-lowering agents:
HMG-CoA reductase inhibitors
\